These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26642349)

  • 1. Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model.
    Takakura K; Shibazaki Y; Yoneyama H; Fujii M; Hashiguchi T; Ito Z; Kajihara M; Misawa T; Homma S; Ohkusa T; Koido S
    PLoS One; 2015; 10(12):e0142981. PubMed ID: 26642349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA HOTAIR promotes invasion of breast cancer cells through chondroitin sulfotransferase CHST15.
    Liu LC; Wang YL; Lin PL; Zhang X; Cheng WC; Liu SH; Chen CJ; Hung Y; Jan CI; Chang LC; Qi X; Hsieh-Wilson LC; Wang SC
    Int J Cancer; 2019 Nov; 145(9):2478-2487. PubMed ID: 30963568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis.
    Suzuki K; Arumugam S; Yokoyama J; Kawauchi Y; Honda Y; Sato H; Aoyagi Y; Terai S; Okazaki K; Suzuki Y; Mizumoto S; Sugahara K; Atreya R; Neurath MF; Watanabe K; Hashiguchi T; Yoneyama H; Asakura H
    PLoS One; 2016; 11(7):e0158967. PubMed ID: 27410685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
    You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
    Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
    Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
    Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma.
    Bai Z; Du Y; Cong L; Cheng Y
    Gene; 2020 Oct; 758():144960. PubMed ID: 32687947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
    Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
    Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small interfering RNA therapy against carbohydrate sulfotransferase 15 inhibits cardiac remodeling in rats with dilated cardiomyopathy.
    Watanabe K; Arumugam S; Sreedhar R; Thandavarayan RA; Nakamura T; Nakamura M; Harima M; Yoneyama H; Suzuki K
    Cell Signal; 2015 Jul; 27(7):1517-24. PubMed ID: 25778904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHST15 promotes the proliferation of TE‑1 cells via multiple pathways in esophageal cancer.
    Wang X; Cheng G; Zhang T; Deng L; Xu K; Xu X; Wang W; Zhou Z; Feng Q; Chen D; Bi N; Wang L
    Oncol Rep; 2020 Jan; 43(1):75-86. PubMed ID: 31746400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).
    Li Z; Lin P; Gao C; Peng C; Liu S; Gao H; Wang B; Wang J; Niu J; Niu W
    Tumour Biol; 2016 Apr; 37(4):5117-31. PubMed ID: 26547582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of tumoral carbohydrate sulfotransferase 15 reactivates lymph node pancreatic cancer T cells in mice.
    Ye J; Suizu F; Yamakawa K; Mukai Y; Kato M; Yoneyama H; Yahagi N; Matsuda Y
    Eur J Immunol; 2023 Sep; 53(9):e2250160. PubMed ID: 37248998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andrographolide suppresses the malignancy of pancreatic cancer via alleviating DNMT3B-dependent repression of tumor suppressor gene ZNF382.
    Zhuang KR; Chen CF; Chan HY; Wang SE; Lee DH; Chen SC; Shyr BU; Chou YJ; Chen CC; Yuan SH; Chang YI; Lee HT; Fu SL
    Phytomedicine; 2024 Sep; 132():155860. PubMed ID: 38991252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
    Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
    Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ProNGF siRNA inhibits cell proliferation and invasion of pancreatic cancer cells and promotes anoikis.
    Xu J; Song J; Yang X; Guo J; Wang T; Zhuo W
    Biomed Pharmacother; 2019 Mar; 111():1066-1073. PubMed ID: 30841420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.